KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Globus Medical (GMED) Acquisitions (2016 - 2024)

Historic Acquisitions for Globus Medical (GMED) over the last 12 years, with Q3 2024 value amounting to $100000.0.

  • Globus Medical's Acquisitions fell 9996.59% to $100000.0 in Q3 2024 from the same period last year, while for Sep 2025 it was $5.0 million, marking a year-over-year decrease of 7172.67%. This contributed to the annual value of $17.6 million for FY2024, which is 9404.28% down from last year.
  • Per Globus Medical's latest filing, its Acquisitions stood at $100000.0 for Q3 2024, which was down 9996.59% from $4.9 million recorded in Q2 2024.
  • Globus Medical's 5-year Acquisitions high stood at $293.4 million for Q3 2023, and its period low was $100000.0 during Q3 2024.
  • For the 4-year period, Globus Medical's Acquisitions averaged around $35.7 million, with its median value being $3.8 million (2023).
  • Per our database at Business Quant, Globus Medical's Acquisitions soared by 54404.76% in 2020 and then crashed by 9996.59% in 2024.
  • Globus Medical's Acquisitions (Quarter) stood at $1.5 million in 2020, then skyrocketed by 1928.15% to $30.3 million in 2022, then skyrocketed by 869.48% to $293.4 million in 2023, then tumbled by 99.97% to $100000.0 in 2024.
  • Its last three reported values are $100000.0 in Q3 2024, $4.9 million for Q2 2024, and $12.6 million during Q1 2024.